131 related articles for article (PubMed ID: 37862954)
21. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
[TBL] [Abstract][Full Text] [Related]
22. Relationship of Serum Bile Acids with Fat Deposition in the Pancreas, Liver, and Skeletal Muscle.
Al-Ani Z; Ko J; Petrov MS
Clin Exp Gastroenterol; 2023; 16():137-146. PubMed ID: 37605644
[TBL] [Abstract][Full Text] [Related]
23. [Changes of serum lipid profiles and the correlation analysis in clinic-pathological features of pancreatic cancer patients].
Yang J; Fan ZY; Li YZ; Liu SJ; Meng YF; Xu JW; Wang L; Zhan HX
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):680-687. PubMed ID: 35775261
[No Abstract] [Full Text] [Related]
24. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
[TBL] [Abstract][Full Text] [Related]
25. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
Wu WC; Wang CY
Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
[TBL] [Abstract][Full Text] [Related]
26. Fat depots, free fatty acids, and dyslipidemia.
Ebbert JO; Jensen MD
Nutrients; 2013 Feb; 5(2):498-508. PubMed ID: 23434905
[TBL] [Abstract][Full Text] [Related]
27. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
[TBL] [Abstract][Full Text] [Related]
28. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
[TBL] [Abstract][Full Text] [Related]
30. Serum lipid profile as a biomarker of intra-pancreatic fat deposition: A nested cross-sectional study.
Singh RG; Nguyen NN; Cervantes A; Cho J; Petrov MS
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):956-964. PubMed ID: 31353204
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
32. The metabolic basis of atherogenic dyslipidemia.
Vinik AI
Clin Cornerstone; 2005; 7(2-3):27-35. PubMed ID: 16473258
[TBL] [Abstract][Full Text] [Related]
33. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
Kato S; Iwasaki A; Kurita Y; Arimoto J; Yamamoto T; Hasegawa S; Sato T; Imajo K; Hosono K; Kobayashi N; Yoneda M; Higurashi T; Kubota K; Utsunomiya D; Nakajima A
PLoS One; 2019; 14(12):e0224921. PubMed ID: 31790429
[TBL] [Abstract][Full Text] [Related]
36. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Raja V; Aguiar C; Alsayed N; Chibber YS; ElBadawi H; Ezhov M; Hermans MP; Pandey RC; Ray KK; Tokgözoglu L; Zambon A; Berrou JP; Farnier M
Atherosclerosis; 2023 Oct; 383():117312. PubMed ID: 37826864
[TBL] [Abstract][Full Text] [Related]
37. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.
Jacobs S; Schiller K; Jansen E; Fritsche A; Weikert C; di Giuseppe R; Boeing H; Schulze MB; Kröger J
Eur J Clin Nutr; 2014 Apr; 68(4):517-25. PubMed ID: 24569539
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
[TBL] [Abstract][Full Text] [Related]
39. Dyslipidemia and its association with meibomian gland dysfunction.
Braich PS; Howard MK; Singh JS
Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
[TBL] [Abstract][Full Text] [Related]
40. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
